Archive for December, 2016

New research examines the link between patterns in the paintings of famous artists and the onset of neurodegenerative diseases such as Parkinson’s. Read & Research Alzheimer’s More

Be the first to comment

An observational study has uncovered a link between high use of the cholesterol-lowering drugs, statins, and lower risk of Alzheimer’s disease. Read & Research Alzheimer’s More

Be the first to comment

Alzheimer’s is the most common types of dementia, but not the only one. Find out more about the different types, how to spot them, and some lifestyle tips. Read & Research Alzheimer’s More

Be the first to comment

Subjective cognitive decline (SCD) is a risk factor for mild cognitive impairment (MCI) and Alzheimer disease (AD). Although sleep has been shown to be altered in MCI and AD, little is known about sleep in SCD. Read & Research Alzheimer’s More

Be the first to comment

Researchers reveal how a smell test significantly boosted the accuracy of diagnosis for mild cognitive impairment and Alzheimer’s disease. Read & Research Alzheimer’s More

Be the first to comment

Recent literature proposes that amyloid-β and phosphorylated tau (p-tau) synergism accelerates biomarker abnormalities in controls. Yet, it remains to be answered whether this synergism is the driving force behind Alzheimer disease (AD) dementia. Read & Research Alzheimer’s More

Be the first to comment

A new genetic disease which results in neurodegeneration has been discovered by experts at the University of Sussex. Read & Research Alzheimer’s More

Be the first to comment

Scientists at Washington University School of Medicine in St. Louis have detailed the structure of a molecule that has been implicated in Alzheimer’s disease. Read & Research Alzheimer’s More

Be the first to comment

We read with interest the research article from Casanova et al. for an upcoming edition of Alzheimer’s & Dementia (2016, article in press). We appreciate the efforts that these investigators have expended in attempting to replicate our plasma lipidomic findings in preclinical Alzheimer’s disease [1]. We enthusiastically endorse independent validation of Read & Research Alzheimer’s More

Be the first to comment

Breakthrough findings demonstrate a possible target and potential drug treatment to restore memory loss and extend life span in mice with neurodegeneration. Read & Research Alzheimer’s More

Be the first to comment

Recent population studies suggest an intriguing inverse relationship between several types of cancer and neurodegenerative diseases, including Alzheimer’s disease. Understanding the intersection of the underlying biology for these two distinct families of diseases with one another may offer novel approaches to identify new therapeutic approaches and possible opportunities to repurpose Read & Research Alzheimer’s More

Be the first to comment

A drug which is used to treat the common eye disease glaucoma may have potential as a treatment for Alzheimer’s disease, according to scientists at UCL. Read & Research Alzheimer’s More

Be the first to comment

Exactly what causes Alzheimer’s disease is unknown. Age is a major risk factor, but scientists are also investigating genetic factors and heredity. Read & Research Alzheimer’s More

Be the first to comment

Little is known about the role of the brain’s immune system in Alzheimer’s disease. Read & Research Alzheimer’s More

Be the first to comment

People with protein present in their urine may have an increased risk of developing cognitive impairment or dementia in later life, new research finds. Read & Research Alzheimer’s More

Be the first to comment

Sundowner’s syndrome often affects older people with dementia, causing them to feel agitated in the early evening. Find out how to reduce the impact. Read & Research Alzheimer’s More

Be the first to comment

Researchers at Karolinska Institutet have developed a method for producing flexible plastic electrodes capable of releasing the neurotransmitter acetylcholine upon an electrical trigger. Read & Research Alzheimer’s More

Be the first to comment

Given that football players have a high risk of head trauma, a new study investigates if this also puts them at risk of brain degenerative disease. Read & Research Alzheimer’s More

Be the first to comment

What is Diogenes syndrome and who does it affect? Learn about the signs, symptoms, what treatments are available, and tips for caregivers. Read & Research Alzheimer’s More

Be the first to comment

Numerous diagnostic criteria have tried to tackle the variability in clinical manifestations and problematic diagnosis of vascular cognitive impairment (VCI) but none have been universally accepted. These criteria have not been readily comparable, impacting on clinical diagnosis rates and in turn prevalence estimates, research, and treatment. Read & Research Alzheimer’s More

Be the first to comment

Scientists from the Florida campus of The Scripps Research Institute (TSRI) have made an important discovery toward the development of drugs to treat age-related memory loss in diseases like… Read & Research Alzheimer’s More

Be the first to comment

Alzheimer’s disease affects more than 35 million people, a number that is expected to increase in the coming years. Read & Research Alzheimer’s More

Be the first to comment

We hypothesized that common Alzheimer’s disease (AD)-associated variants within the triggering receptor expressed on myeloid (TREM) gene cluster influence disease through gene expression. Read & Research Alzheimer’s More

Be the first to comment

Study shows light therapy that induces gamma oscillations in the brain substantially reduces beta-amyloid plaques in a mouse model of Alzheimer’s disease. Read & Research Alzheimer’s More

Be the first to comment

The hip fracture risk factors are generally similar among those with and without Alzheimer’s disease, according to a recent study from the University of Eastern Finland. Read & Research Alzheimer’s More

Be the first to comment

Read & Research Alzheimer’s More

Be the first to comment

The overall goal of the Alzheimer’s Disease Neuroimaging Initiative (ADNI) is to validate biomarkers for Alzheimer’s disease (AD) clinical trials. ADNI-3, which began on August 1, 2016, is a 5-year renewal of the current ADNI-2 study. Read & Research Alzheimer’s More

Be the first to comment

Women with dementia have fewer visits to the GP, receive less health monitoring and take more potentially harmful medication than men with dementia, new UCL research reveals. Read & Research Alzheimer’s More

Be the first to comment

A study in a mouse model of Alzheimer’s finds a potential link between early bone loss and degeneration in an area of the brain that makes serotonin. Read & Research Alzheimer’s More

Be the first to comment